Cloning And Mutagenesis Market on Track for Strong Growth, Estimated to Grow at 19.3% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cloning And Mutagenesis Market Through 2025?
The scale of the cloning and mutagenesis market has swiftly expanded in the last few years. The market is projected to surge from a value of $2.98 billion in 2024 to $3.56 billion in 2025, showcasing a compound annual growth rate (CAGR) of 19.5%. This growth during the historic period can be traced back to the progress in genetic research, escalating needs in pharmaceutical research, the emergence of genetic engineering in farming practices, applications in biomedical research, and groundbreaking uses in molecular biology.

What's the Projected Size of the Global Cloning And Mutagenesis Market by 2029?
Anticipations are high for the cloning and mutagenesis sector to experience a considerable increase in the coming years, with estimates showing a market value of "$7.2 billion by 2029, thanks to a potent compound annual growth rate (CAGR) of 19.3%. The swell during this estimated period is as a result of numerous factors: the growth of gene therapy applications, an escalating need for individualized medication, advancements in functional genomics strides in synthetic biology, and utilization in agricultural biotechnology. During the projected period, the industry is set to see some key trends like gene-editing targeted at therapeutics, increased precision and specificity, customizable molecular tools, further applications in the agric sector, along with ethical and regulatory considerations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report

Top Growth Drivers in the Cloning And Mutagenesis Industry: What's Accelerating the Market?
The cloning and mutagenesis market is predicted to experience an upward trajectory due to the increasing consumer need for genetically altered products. A genetically modified product has been transformed through genetic engineering to deliberately alter an organism's genes, introducing new properties or elements. Cloning, a procedure that creates exact genetic duplicates of various living species, is resistant to insects and plants and utilized in the medical field for gene therapy. Thus, the increasing need for genetically modified products propels the cloning and mutagenesis market's expansion. For example, in February 2023, data from the yearly report released by Bayar AG, a biotechnology and pharmaceutical organization based in Germany, revealed substantial growth in the annual sales of their crop sciences and pharmaceutical sector which comprise genetically modified products. The annual sales for the crop sciences sector increased from $22,314.79 million in 2021 to $27,794.38 million in 2022, reflecting the growing need for genetically modified products is fueling the expansion of the cloning and mutagenesis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp

What Trends Will Shape the Cloning And Mutagenesis Market Through 2029 and Beyond?
Leading corporations in the cloning and mutagenesis market are leveraging innovative technologies such as bacteriophage genome modification to stay competitive. These allow deliberate alteration in the genetic content of bacteriophages, viruses that attack bacteria, for diverse research, therapeutic, or industrial purposes. For instance, iNtRON Biotechnology, a biotech firm based in South Korea, unveiled its 2nd generation technology for Robot Bacteriophage in October 2022. This breakthrough employs random transposon mutagenesis for bacteriophage genome modification. Coupled with an earlier developed customized CRISPR/Cas system, it aids in identifying and eliminating non-essential genes in the bacteriophage genome. The firm's objective is to create and manufacture bacteriophages with preferred traits, promoting the production of immunotherapeutic agents and antiviral treatments.

What Are the Main Segments in the Cloning And Mutagenesis Market?
The cloning and mutagenesis market covered in this report is segmented -

1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User

Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes, Vector Systems, Accessories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10541&type=smp

Which Top Companies are Driving Growth in the Cloning And Mutagenesis Market?
Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

Which Regions Will Dominate the Cloning And Mutagenesis Market Through 2029?
North America was the largest region in the cloning and mutagenesis market in 2024.Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10541

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.